(Q33471561)

27 July 2017

title

Lactitol versus lactulose in the treatment of chronic hepatic encephalopathy. A double-blind, randomised, cross-over study (English)

1 reference

27 July 2017

1 reference

Morgan MY

1

1 reference

27 July 2017

Hawley KE

series ordinal

2

1 reference

27 July 2017

Stambuk D

series ordinal

3

1 reference

27 July 2017

language of work or name

1 reference

1 April 1987

1 reference

27 July 2017

published in

Journal of Hepatology

1 reference

27 July 2017

volume

4

1 reference

27 July 2017

issue

2

1 reference

27 July 2017

page(s)

236-244

1 reference

Food additives derived from lactose: lactitol and lactitol palmitate

27 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2887%2980086-7

7 January 2021

Lactitol in the treatment of chronic hepatic encephalopathy: an open comparison with lactulose

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2887%2980086-7

7 January 2021

Trailmaking and number-connection tests in the assessment of mental state in portal systemic encephalopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2887%2980086-7

7 January 2021

The Revised Kendrick Battery: Clinical studies

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2887%2980086-7

7 January 2021

PORTAL-SYSTEMIC ENCEPHALOPATHY NEUROLOGICAL COMPLICATIONS OF LIVER DISEASE

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2887%2980086-7

7 January 2021

Episodic stupor associated with an Eck fistula in the human with particular reference to the metabolism of ammonia

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2887%2980086-7

7 January 2021

Detection of hepatic encephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2887%2980086-7

7 January 2021

The widening spectrum of neurological damage in liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2887%2980086-7

7 January 2021

Psychomotor performance defects in cirrhotic patients without overt encephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2887%2980086-7

7 January 2021

Treatment of hepatic encephalopathy with metronidazole

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2887%2980086-7

7 January 2021

Progress in the treatment of chronic portasystemic encephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2887%2980086-7

7 January 2021

Absorption of Lactulose in Man

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2887%2980086-7

7 January 2021

Ammonia production by intestinal bacteria

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2887%2980086-7

7 January 2021

Faecal ammonia and pH during lactulose administration in man: comparison with other cathartics

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2887%2980086-7

7 January 2021

Hypernatremia after the administration of lactulose

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2887%2980086-7

7 January 2021

10.1016/S0168-8278(87)80086-7

Identifiers

DOI

1 reference

27 July 2017

1 reference